Brief: Zynerba Says Meeting With FDA Planned For Q4 To Discuss Regulatory Path Forward For Zygel

Zynerba Pharmaceuticals

14/09/2020 12:08

Sept 14 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS PROVIDES UPDATE ON RECENT
MILESTONES
    * ZYNERBA PHARMACEUTICALS INC - FDA SUGGESTS PURSUING
INDIVIDUAL
SYNDROMES IN DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES
PROGRAM
    * ZYNERBA PHARMACEUTICALS INC - MEETING WITH FDA PLANNED FOR
4Q2020 TO DISCUSS REGULATORY PATH FORWARD FOR ZYGEL
    * ZYNERBA PHARMACEUTICALS INC - COMPANY IS IN PROCESS OF
FINALIZING ITS EVALUATION OF WHICH EPILEPTIC SYNDROMES IT MAY
PURSUE WITH ZYGEL

Source text for Eikon:  ID:nGNX2l9dD0 
Further company coverage:  ZYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))